| Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2 ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ... The Journal of clinical endocrinology & metabolism 86 (12), 5658-5671, 2001 | 2616 | 2001 |
| Bisphosphonate‐associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research S Khosla, D Burr, J Cauley, DW Dempster, PR Ebeling, D Felsenberg, ... Journal of bone and mineral research 22 (10), 1479-1491, 2007 | 2002 | 2007 |
| Medullary thyroid cancer: management guidelines of the American Thyroid Association RT Kloos, C Eng, DB Evans, GL Francis, RF Gagel, H Gharib, JF Moley, ... Thyroid 19 (6), 565-612, 2009 | 1727 | 2009 |
| Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial SA Wells Jr, BG Robinson, RF Gagel, H Dralle, JA Fagin, M Santoro, ... Journal of clinical oncology 30 (2), 134-141, 2012 | 1701 | 2012 |
| The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, RF Gagel, ... Jama 276 (19), 1575-1579, 1996 | 1467 | 1996 |
| Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy PM Thomas, GJ Cote, N Wohllk, B Haddad, PM Mathew, W Rabl, ... Science 268 (5209), 426-429, 1995 | 1035 | 1995 |
| Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates AO Hoff, BB Toth, K Altundag, MM Johnson, CL Warneke, M Hu, A Nooka, ... Journal of Bone and Mineral Research 23 (6), 826-836, 2008 | 852 | 2008 |
| Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer R Kurzrock, SI Sherman, DW Ball, AA Forastiere, RB Cohen, R Mehra, ... Journal of Clinical Oncology 29 (19), 2660-2666, 2011 | 640 | 2011 |
| Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease H Neumann, DP Berger, G Sigmund, U Blum, D Schmidt, RJ Parmer, ... New England Journal of Medicine 329 (21), 1531-1538, 1993 | 611 | 1993 |
| Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer SA Wells Jr, JE Gosnell, RF Gagel, J Moley, D Pfister, JA Sosa, M Skinner, ... Journal of Clinical Oncology 28 (5), 767-772, 2010 | 606 | 2010 |
| American Thyroid Association guidelines task force on medullary thyroid carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma SA Wells Jr, SL Asa, H Dralle, R Elisei, DB Evans, RF Gagel, N Lee, ... Thyroid 25 (6), 567-610, 2015 | 463 | 2015 |
| The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a RF Gagel, AH Tashjian Jr, T Cummings, N Papathanasopoulos, ... New England Journal of Medicine 318 (8), 478-484, 1988 | 437 | 1988 |
| Adrenal cortical carcinoma APB Dackiw, JE Lee, RF Gagel, DB Evans World journal of surgery 25 (7), 914-926, 2001 | 429 | 2001 |
| RET Proto-Oncogene: A Review and Update of Genotype–Phenotype Correlations in Hereditary Medullary Thyroid Cancer and Associated Endocrine Tumors MA Kouvaraki, SE Shapiro, ND Perrier, GJ Cote, RF Gagel, AO Hoff, ... Thyroid 15 (6), 531-544, 2005 | 375 | 2005 |
| Parathyroid carcinoma: a 22‐year experience NL Busaidy, C Jimenez, MA Habra, PN Schultz, AK El‐Naggar, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2004 | 367 | 2004 |
| American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules H Gharib, E Papini, R Valcavi, HJ Baskin, A Crescenzi, ME Dottorini, ... Endocrine Practice 12 (1), 63-102, 2006 | 347 | 2006 |
| Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium LM Mulligan, DJ Marsh, BG Robinson, I Schuffenecker, J Zedenius, ... Journal of internal medicine 238 (4), 343-346, 1995 | 340 | 1995 |
| Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study CB Newman, S Melmed, PJ Snyder, WF Young, LD Boyajy, R Levy, ... The Journal of Clinical Endocrinology & Metabolism 80 (9), 2768-2775, 1995 | 337 | 1995 |
| ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes JG Guillem, WC Wood, JF Moley, A Berchuck, BY Karlan, DG Mutch, ... Journal of Clinical Oncology 24 (28), 4642-4660, 2006 | 336 | 2006 |
| Octreotide as primary therapy for acromegaly CB Newman, S Melmed, A George, D Torigian, M Duhaney, P Snyder, ... The Journal of Clinical Endocrinology & Metabolism 83 (9), 3034-3040, 1998 | 323 | 1998 |
